The latest positive readout comes from the APPLY-PNH study, which pitted iptacopan against AstraZeneca/Alexion's anti-C5 antibodies Soliris (eculizumab) and Ultomiris (ravulizumab) in adults with ...

Apellis Pharma and partner Sobi have won EU approval for their paroxysmal nocturnal haemoglobinuria (PNH) drug pegcetacoplan in Europe, with a more restricted label than in the US. The European ...

Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired, potentially life-threatening disorder linked to a specific gene. It can occur at any age but most often is diagnosed in young adults. PNH ...

by Dr Thara Balasubramaniam, Dr Richard Kelly, Dr Anita Hill and Professor Peter Hillmen ...

At close: 5:29:37 PM GMT+2 ...

A red blood cell (RBC) count measures the number of red blood cells in a sample of blood. It is part of a battery of tests called a complete blood count (CBC) which measures the different types and ...

Correct ECG interpretation is fundamental to patient management in paroxysmal supraventricular tachycardia. This study aimed to assess the ability of A&E SHOs to interpret the ECG in this setting.

Correspondence to: Professor AJ Lees, Reta Lila Weston Institute of Neurological Studies, Royal Free and University College London Medical School, Windeyer Institute of Medical Science, 46 Cleveland ...

The company will make a total investment of $23B over the next five years, creating: Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities New ...